Other studies have shown that the expression of circ-RNF111 is increased in paclitaxel-resistant tissues and cells, and knocking out circ-RNF111 reduces paclitaxel’s effectiveness on breast cancer cells (Liang et al., 2019). Here, RNF111 is linked to breast cancer.